Population Pharmacokinetic Meta-Analysis to Bridge Ferumoxytol Plasma Pharmacokinetics Across Populations

BACKGROUND: Ferumoxytol is approved for the treatment of iron-deficiency anaemia (IDA) in adult patients with chronic kidney disease (CKD). Ferumoxytol has recently been investigated for use in all-cause IDA. This analysis was employed to bridge ferumoxytol pharmacokinetics (PK) across populations o...

Descripción completa

Detalles Bibliográficos
Autores principales: Plock, Nele, Facius, Axel, Lahu, Gezim, Wood, Nolan, Frigo, Timothy, Deveney, Aaron, Aceves, Pau
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368844/
https://www.ncbi.nlm.nih.gov/pubmed/25370033
http://dx.doi.org/10.1007/s40262-014-0203-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368844/
https://www.ncbi.nlm.nih.gov/pubmed/25370033
http://dx.doi.org/10.1007/s40262-014-0203-9

Ejemplares similares